NZ601969A - Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane - Google Patents

Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane

Info

Publication number
NZ601969A
NZ601969A NZ601969A NZ60196905A NZ601969A NZ 601969 A NZ601969 A NZ 601969A NZ 601969 A NZ601969 A NZ 601969A NZ 60196905 A NZ60196905 A NZ 60196905A NZ 601969 A NZ601969 A NZ 601969A
Authority
NZ
New Zealand
Prior art keywords
composition
taste
calcium
drug
membrane
Prior art date
Application number
NZ601969A
Inventor
Jin-Wang Lai
Ken Qian
Gopi Venkatesh
Original Assignee
Aptalis Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/213,266 external-priority patent/US20060105038A1/en
Application filed by Aptalis Pharma Ltd filed Critical Aptalis Pharma Ltd
Publication of NZ601969A publication Critical patent/NZ601969A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ABSTRACT - 601969 The disclosure relates to a taste-masked multiparticulate pharmaceutical composition comprising: (a) a drug-containing core particle, and (b) a solvent-coacervated membrane on said drug-containing core particle comprising a combination of a water-insoluble polymer and a gastrosoluble, organic or inorganic pore-former at a ratio ranging from about 95/5 to about 50/050, said membrane having a thickness of from about 5% to about 50% by weight based on the weight of the coated particle and an average particle size of not more than about 400μm, wherein said composition has the following properties: (1) said composition has acceptable taste-masking when the composition is placed in the oral cavity for at least about 60 seconds; and (2) said composition releases not less than about 60% of the dose in 30 min when tested for dissolution using United States Pharmacopoeia Apparatus ! (Baskets @ 100 rpm in 900 mL of pH 1.2 buffer), and wherein said water insoluble polymer is selected from the group consisting of ethylcellulose, cellulose acetate, cellulose acetate butyrate, polyvinyl acetate, neutral methacrylic ester copolymer, ammonio-methacrylate copolymers and mixtures thereof, and said gastrosoluble organic or inorganic pore-former is selected from the group consisting of calcium carbonate, calcium phosphate, calcium saccharide, calcium succinate, calcium tartrate, ferric acetate, ferric hydroxide, ferric phosphate, magnesium carbonate, magnesium citrate, magnesium hydroxide, magnesium phosphate, and mixtures thereof. Also disclosed is a method of manufacturing the taste-masked multi-particulate composition comprising the above features.
NZ601969A 2004-11-12 2005-10-13 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane NZ601969A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62752504P 2004-11-12 2004-11-12
US11/213,266 US20060105038A1 (en) 2004-11-12 2005-08-26 Taste-masked pharmaceutical compositions prepared by coacervation
NZ58910905 2005-10-13

Publications (1)

Publication Number Publication Date
NZ601969A true NZ601969A (en) 2014-03-28

Family

ID=50542736

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ601969A NZ601969A (en) 2004-11-12 2005-10-13 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane

Country Status (1)

Country Link
NZ (1) NZ601969A (en)

Similar Documents

Publication Publication Date Title
US5639476A (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
AU2011263780B2 (en) Diversion-resistant microgranules and microtablets
US7070806B2 (en) Controlled release formulations coated with aqueous dispersions of acrylic polymers
TWI469781B (en) Use of binders for manufacturing storage stable formulations
US5211957A (en) Solid rapidly disintegrating dosage form
WO2007000778A3 (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
RU2011150228A (en) FILM COATING SYSTEMS FOR IMMEDIATE RELEASE PRODUCTS CREATING AN ENHANCED MOISTURE BARRIER AND SUBSTRATES WITH SUCH COATING
NZ237823A (en) Formulation of particles comprising an active ingredient core surrounded by two polymer membranes, one soluble at ph over 5 and one insoluble but permeable to gastrointestinal fluid
RS51934B (en) Modified-release tablet of bupropion hydrochloride
CA2193129A1 (en) Transdermal drug delivery system
AU6042796A (en) Controlled release formulation having a preformed passageway
WO2004108067A3 (en) Programmed drug delivery system
HRP920854A2 (en) New pharmaceutical preparation for oral use
US20080226738A1 (en) Sustained-Released Pellet Formulation of Alpha1-Receptor Antagonist and Process For the Preparation Thereof
RU2003133446A (en) ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF CARDIAC DISEASES AND DISEASES PROCESSING WITH DISEASE OF THE CIRCULATION
TW201542243A (en) A delayed release drug formulation
AU619261B2 (en) Solid rapidly disintegrating dosage form
US20130129827A1 (en) Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
RU2013150254A (en) Oral Solid Product of the Combined Anti-Tuberculosis Drug and Method for its Preparation
CA2374039A1 (en) Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
NZ601969A (en) Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
US12109214B2 (en) Formulation and treatment methods
WO2009087663A2 (en) Oral controlled release coated tablet
SE9903879D0 (en) Multipor food protection
WO2005065641A3 (en) Non-disintegrating oral solid composition of high dose of water soluble drugs

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE MISSING INVENTOR HAS BEEN ADDED (1355696, LAI, JIN-WANG; 1355697, QIAN, KEN; 1355698, VENKATESH, GOPI)

Effective date: 20140217

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 13 OCT 2015 BY AJ PARK

Effective date: 20141002

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 OCT 2016 BY COMPUTER PACKAGES INC

Effective date: 20150918

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 13 OCT 2017 BY COMPUTER PACKAGES INC

Effective date: 20160920

LAPS Patent lapsed